- Home
- APLT vs AORT Comparison
APLT vs AORT Comparison
Compare APLT & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- AORT
- Stock Information
- Founded
- APLT 2016
- AORT 1984
- Country
- APLT United States
- AORT United States
- Employees
- APLT N/A
- AORT N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- AORT Medical/Dental Instruments
- Sector
- APLT Health Care
- AORT Health Care
- Exchange
- APLT Nasdaq
- AORT Nasdaq
- Market Cap
- APLT 52.9M
- AORT 1.4B
- IPO Year
- APLT 2019
- AORT 1993
- Fundamental
- Price
- APLT $0.33
- AORT $31.74
- Analyst Decision
- APLT Buy
- AORT Strong Buy
- Analyst Count
- APLT 7
- AORT 5
- Target Price
- APLT $6.10
- AORT $32.40
- AVG Volume (30 Days)
- APLT 2.3M
- AORT 321.1K
- Earning Date
- APLT 08-06-2025
- AORT 08-07-2025
- Dividend Yield
- APLT N/A
- AORT N/A
- EPS Growth
- APLT N/A
- AORT N/A
- EPS
- APLT N/A
- AORT N/A
- Revenue
- APLT $265,000.00
- AORT $390,084,000.00
- Revenue This Year
- APLT $1,768.13
- AORT $12.18
- Revenue Next Year
- APLT $292.85
- AORT $10.39
- P/E Ratio
- APLT N/A
- AORT N/A
- Revenue Growth
- APLT N/A
- AORT 5.94
- 52 Week Low
- APLT $0.30
- AORT $21.97
- 52 Week High
- APLT $10.62
- AORT $32.33
- Technical
- Relative Strength Index (RSI)
- APLT 43.25
- AORT 61.57
- Support Level
- APLT $0.30
- AORT $30.44
- Resistance Level
- APLT $0.36
- AORT $31.66
- Average True Range (ATR)
- APLT 0.03
- AORT 0.67
- MACD
- APLT -0.00
- AORT -0.01
- Stochastic Oscillator
- APLT 22.22
- AORT 73.30
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.